title: Active Component of Danshen (Salvia miltiorrhiza Bunge), Tanshinone I, Attenuates Lung Tumorigenesis via Inhibitions of VEGF, Cyclin A, and Cyclin B Expressions.
abstract: Tanshinone I (T1) and tanshinone II (T2) are the major diterpenes isolated from Danshen (Salvia miltiorrhiza Bunge). Three human lung adenocarcinoma cell lines, A549, CL1-0, and CL1-5, were treated with T1 and T2 for the in vitro antitumor test. Results showed that T1 was more effective than T2 in inhibiting the growth of lung cancer cells via suppressing the expression of VEGF, Cyclin A, and Cyclin B proteins in a dose-dependent manner. Moreover, a transgenic mice model of the human vascular endothelial growth factor-A165 (hVEGF-A 165) gene-induced pulmonary tumor was further treated with T1 for the in vivo lung cancer therapy test. T1 significantly attenuated hVEGF-A165 overexpression to normal levels of the transgenic mice (Tg) that were pretreated with human monocytic leukemia THP-1 cell-derived conditioned medium (CM). It also suppressed the formation of lung adenocarcinoma tumors (16.7%) compared with two placebo groups (50% for Tg/Placebo and 83.3% for Tg/CM/Placebo; P < 0.01). This antitumor effect is likely to slow the progression of cells through the S and G2/M phases of the cell cycle. Blocking of the tumor-activated cell cycle pathway may be a critical mechanism for the observed antitumorigenic effects of T1 treatment on vasculogenesis and angiogenesis.
authors: Department of Life Sciences, Agricultural Biotechnology Center, National Chung Hsing University, Taichung 402, Taiwan.
authors: Yu-Tang
authors: YT
authors: Tung
authors: Hsiao-Ling
authors: HL
authors: Chen
authors: Cheng-Yu
authors: CY
authors: Lee
authors: Yu-Ching
authors: YC
authors: Chou
authors: Po-Ying
authors: PY
authors: Lee
authors: Hsin-Chung
authors: HC
authors: Tsai
authors: Yi-Ling
authors: YL
authors: Lin
authors: Chuan-Mu
authors: CM
authors: Chen
references: Planta Med. 1997 Aug;63(4):339-42
references: 9270379
references: Med Res Rev. 2007 Jan;27(1):133-48
references: 16888751
references: Am J Chin Med. 1991;19(3-4):207-16
references: 1767792
references: Phytomedicine. 2003 Nov;10(8):682-5
references: 14692730
references: Phytomedicine. 2010 Dec 15;18(1):16-24
references: 20637573
references: Mol Nutr Food Res. 2011 Jul;55(7):1036-43
references: 21538854
references: J Thorac Cardiovasc Surg. 2003 Nov;126(5):1404-10
references: 14666012
references: Cancer Lett. 2009 Nov 28;285(2):127-33
references: 19477063
references: Cancer Biol Ther. 2008 May;7(5):777-82
references: 18376139
references: Int J Epidemiol. 2003 Aug;32(4):592-9
references: 12913035
references: Zhongguo Zhong Yao Za Zhi. 2005 Feb;30(3):207-11
references: 15719642
references: Vaccine. 2008 Feb 13;26(7):891-8
references: 18207613
references: Arch Dermatol. 2008 Dec;144(12):1571-5
references: 19075139
references: Clin Cancer Res. 2003 Feb;9(2):729-37
references: 12576442
references: Carcinogenesis. 2008 Oct;29(10):1885-92
references: 18586687
references: Mol Cancer Ther. 2008 Nov;7(11):3527-38
references: 19001436
references: Biometals. 2010 Jun;23(3):543-54
references: 20148305
references: Drugs. 1999 Jul;58(1):17-38
references: 10439927
references: Nat Rev Cancer. 2002 Oct;2(10):795-803
references: 12360282
references: Cancer Cell. 2002 Feb;1(1):49-52
references: 12086887
references: J Agric Food Chem. 2007 Jun 13;55(12):4670-7
references: 17489602
references: Endocr Rev. 1997 Feb;18(1):4-25
references: 9034784
references: J Clin Oncol. 2005 Feb 10;23(5):953-64
references: 15598976
references: Int J Oncol. 2008 Sep;33(3):485-91
references: 18695877
references: Chest. 2000 Apr;117(4):1162-72
references: 10767254
references: Nature. 2002 Dec 19-26;420(6917):860-7
references: 12490959
references: J Infect Dis. 2009 Feb 15;199(4):590-8
references: 19125673
references: Chem Pharm Bull (Tokyo). 2005 May;53(5):508-14
references: 15863921
references: Int J Epidemiol. 1997 Feb;26(1):24-31
references: 9126500
references: BMC Dev Biol. 2010 Aug 12;10:88
references: 20704734
references: Respir Res. 2005 Aug 08;6:89
references: 16083514
references: Int J Cancer. 2011 Sep 1;129(5):1042-52
references: 20848589
references: Carcinogenesis. 2006 Mar;27(3):429-36
references: 16272577
references: Exp Mol Med. 1999 Dec 31;31(4):174-8
references: 10630370
references: J Ethnopharmacol. 1999 Dec 15;68(1-3):121-7
references: 10624871
references: J Clin Pharmacol. 2005 Dec;45(12):1345-59
references: 16291709